The EXCEL Symposium will be held on the 17th of April 2026 at Alfred Health Innovation & Education Hub Melbourne Australia. This event will focus on ventilation strategies for ECMO patients with keynote speaker Prof Eddy Fan from @UofT and @UHN @efan75 @chodgsonANZICRC

Variability in adult VV #ECMO candidacy: 🔍 international survey: global disparities observed! 📋 82% centers reported formal inclusion/exclusion criteria; very few shared identical contraindications 🚦 95% have absolute contraindications to initiating ECMO as bridge to recovery;

Are you an ECMO patient? You are invited to our ECMO Patient Support Group on 25/09/2025 11:00 at The Alfred Innovation and Learning Hub Melbourne. After lunch, share your thoughts on how we can increase support for ECMO patients with @iculisah. Register: https://t.co/xT2SrWJg88

Ever wondered what it is like to experience ECMO? At the EXCEL Symposium, Paul and his wife Tania generously shared their ECMO journey and candid experience navigating those challenging times. View: https://t.co/RmlpWjXUDk

EXCEL has enrolled 2700 patients! Thank you to every ECMO patient and their loved ones who take time to answer questions about their recovery after ECMO. This information helps us to understand how we can improve ECMO care @chodgsonANZICRC @anzicrc

EXCEL has enrolled 2600 patients! Thank you to our hard-working Research Coordinators and Investigators who provide education on the Australian and New Zealand ECMO Registry to ECMO patients and their loved ones whilst they are in hospital @chodgsonANZICRC @RachaelParke @anzicrc

Long-term outcomes after VA #ECMO in adults 🔍 multicenter @anzics study investigating incidence of death or new disability at 12 months after VA #ECLS initiation in 🇦🇺 & 🇳🇿 At 12 months 30% pts alive without new disability. Major burden of disability appears to develop in first

Honoured to present at the EXCEL registry symposium on functional outcomes after E-CPR Following E-CPR for IHCA, approx 1/3 are alive at 6 mo and most have a good functional outcome. However, symptoms and complications are common @chodgsonANZICRC @anzicrc

Dear friends and colleagues, It is with overwhelming sadness that we share news of the death of our colleague, mentor and friend, Rinaldo Bellomo. During recent days, both he and his family have received dedicated, expert and compassionate care from some of the finest in our ICU

Long-term outcome of #ECPR vs cCPR in #OHCA 🇦🇺🇳🇿@EXCELoutcomes 🪦 28% ECPR/12% CCPR OHCA survivors at 12 months ⚖️ ECPR cohort younger, more likely to receive bystander CPR ⏱️ median arrest to ROSC/ECMO time longer in ECPR, 61 vs 6' 🧠 majority of ECPR survivors did not have

Evaluating outcome in #ECLS trials? ⚖️ study aimed to report & evaluate the Daily Organ Support for patients on #ECMO = DOSE, new longitudinal ordinal outcome for clinical trials in this population 🗺️ multicentre study: 28 hospitals in 🇦🇺l🇳🇿 🔍DOSE created considering: death; on

@chodgsonANZICRC @EXCELoutcomes @ELSOOrg @IntlECMONet An excellent symposium today on so many levels- science, debate, research from @EXCELoutcomes collaborations and the powerful perspective of an ECMO survivor and their family. Bravo Carol. Very few are truly aware of the work involved to do what you do.

Prof Dion Stub - Debate: Is Impella the answer to managing cardiogenic shock? Can we do a RCT of Impella alone v VA-ECMO?

Prof Vin Pellegrino speaking about use of ECMo for cardiogenic shock- careful case selection!

⁦@EXCELoutcomes⁩ Symposium today - ⁦@ELSOOrg⁩ ⁦@IntlECMONet⁩ Prof McGiffin discussing the sobering outcomes of cardiogenic shock - should we use ECMO? Debate to come next

EXCEL has enrolled 2500 patients! Thanks to our amazing patients, investigators, research coordinators and funders. RPA @SydneyLHD @dgattas @justajuniordoc Bronwyn enrolled our 2500th patient. Join the EXCEL Symposium on Friday 28/03/25. 10 seats left! https://t.co/zFLGr0fOzJ

There is a new primary outcome for ECMO RCTs! Ary Serpa Neto @chodgsonANZICRC @iculisah @BerryConsultant and ECMO Survivors have developed the Daily Ordinal Scale for Patients on ECMO (DOSE) Score. Learn about DOSE at the EXCEL Symposium on March 28th! https://t.co/1I2Gy8Y5zP

Mark Dennis will present EVIDENCE Trial results at the EXCEL Symposium on 28th of March! EVIDENCE Investigators tested the efficacy and value of expedited ALS/ECPR for out of hospital cardiac arrest patients. @HawkmoonHEMS @evidence_trial @IanMarschner @drjasonbendall @NSWHealth

The provision of ECMO services is complex and challenging. It is unclear whether there is a volume of ECMO-outcome relationship. In a registry study of 1232 patients, the EXCEL study group provide a provocative answer, A must read for ECMO practitioners. https://t.co/GFIqkddGJf